Differentiation into musculoskeletal tissues

"Differentiation into musculoskeletal tissues" refers to the collection of developmental processes guiding progenitor cells (such as mesenchymal stem cells) toward becoming specialized musculoskeletal tissues, including bone, cartilage, muscle, tendons, and ligaments. This involves the coordinated action of transcription factors, growth factors, and signaling pathways (such as Sonic hedgehog, Wingless/Integrated (Wnt), Fibroblast growth factor, scleraxis, MyoD, and others). While these molecules and pathways are considered therapeutic targets for regenerative medicine, the process itself is not a single identifiable molecular entity amenable to direct pharmacological targeting. Because "Differentiation into musculoskeletal tissues" is a process and not a molecule, receptor, enzyme, or protein, it should not be considered a canonical therapeutic target. Instead, for structured databases or target mapping, individual molecules governing this differentiation—such as transcription factors (e.g., MyoD, scleraxis), growth factors (e.g., BMP-2, FGF), or surface receptors—should be specified as targets.